Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy

Cancer
Neetha GandikotaHeiko Schöder

Abstract

This study evaluated the need for surveillance imaging in early-stage classic Hodgkin lymphoma (cHL) after planned combined-modality therapy (CMT). Primary early-stage cHL patients who underwent CMT were included. Positron emission tomography (PET)/computed tomography (CT), CT, or both were performed at the initial staging, during or after chemotherapy, and for at least 2 years during follow-up. Imaging studies and medical records were reviewed to determine if and when relapse had occurred. Radiation doses and costs were also calculated from follow-up imaging. The study included 78 patients with a median follow-up of 46 months; 85% of the patients had stage II disease (32% with bulky disease). Four of 77 interim PET scans were positive; none of these patients relapsed during follow-up, which ranged from 24 to 80 months. After a total of 466 follow-up imaging studies (91% with CT and 9% with PET/CT), no cHL relapse was detected. Eleven abnormal findings were noted on surveillance imaging: 9 were false-positives, and 2 were second primary malignancies. The average cumulative dose per patient from follow-up imaging was 107 mSv, which translated into an estimated lifetime excess cancer risk of 0.5%; the estimated total costs were $...Continue Reading

References

Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T A ListerM Tubiana
Jun 8, 2004·British Journal of Haematology·Carol S PortlockDaniel A Filippa
Dec 31, 2005·Radiation Protection Dosimetry·R L DixonD J Simpkin
Sep 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Beverly A GuadagnoloAndrea K Ng
Nov 9, 2007·The New England Journal of Medicine·Christophe FerméUNKNOWN EORTC-GELA H8 Trial
Dec 14, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Teruhiko TerasawaHirokazu Nagai
Feb 12, 2009·Cancer·Olav FavierUNKNOWN European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group and the Groupe d'Etudes des Lymphomes de l
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pier Luigi ZinzaniMichele Baccarani
Apr 25, 2009·The Cancer Journal·Joseph M Connors
Jun 23, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D J SherA K Ng
Nov 11, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H MocikovaM Trneny
Nov 17, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U PetrauschN G Schaefer
Apr 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C A ThompsonJ P Leonard
Sep 8, 2010·The New England Journal of Medicine·Andreas EngertVolker Diehl
Sep 8, 2010·The New England Journal of Medicine·James O Armitage
Apr 6, 2011·Leukemia & Lymphoma·Lauren S MaedaRanjana H Advani
Dec 14, 2011·The New England Journal of Medicine·Ralph M MeyerUNKNOWN Eastern Cooperative Oncology Group
May 10, 2012·Journal of the National Comprehensive Cancer Network : JNCCN·Richard T HoppeUNKNOWN National Comprehensive Cancer Network
Jul 28, 2012·Lancet·William Townsend, David Linch
Jun 25, 2013·International Journal of Radiation Oncology, Biology, Physics·Lena SpechtUNKNOWN ILROG
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Boris BöllPeter Borchmann
Dec 11, 2013·Journal of the American College of Radiology : JACR·Lauren M B BurkeTracy A Jaffe
Mar 25, 2014·European Journal of Radiology·Ravi GuttikondaBrad Pohlman
Apr 18, 2014·Blood·Anna M van EggermondFlora E van Leeuwen
Sep 4, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D A EichenauerUNKNOWN ESMO Guidelines Working Group

❮ Previous
Next ❯

Citations

Oct 27, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Rueda DomínguezM Provencio Pulla
Jun 6, 2020·Journal of the National Comprehensive Cancer Network : JNCCN·Richard T HoppeNdiya Ogba
Apr 25, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Oke GerkeWerner Vach
Aug 12, 2021·The British Journal of Radiology·Marco BrambillaAlfredo Muni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.